TQ05105 Tablet
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TQ05105 Tablet, covering 2025-08-29 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects [Phase 1]